78.9
[]. David Proia, et al. Advantageous therapies for disorders mediated by ikaros or aiolos. WO202203232A.
[2]. James A. Henderson, et al. Abstract LB007: CFT74: A novel, IKZF/3 degrader that demonstrates potent tumor regression in IMiD-resistant multiple myeloma (MM) xenograft models. Cancer Res (202) 8 (3_Supplement): LB007.
H302-H3-H39-H33
P26-P264-P270-P27-P280-P302+P32-P304+P340-P30+P3+P338-P330-P362+P364-P403+P233-P40-P0